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ABSTRACT
Like c-Fos, HBZ (HTLV-I bZIP factor) is able to
interact with c-Jun but differs considerably from
c-Fos in its ability to activate AP-1-responsive genes
since HBZ rather inhibits transcriptional activity of
c-Jun. To better understand the molecular mechan-
isms involved in this down-regulation of c-Jun
activity, a large number of HBZ/c-Fos chimeras
was constructed and analyzed for their ability to
interact with c-Jun, to bind to the AP-1 motif and to
stimulate expression of a reporter gene containing
the collagenase promoter. By this approach, we
demonstrate that the DNA-binding domain of HBZ is
responsible for its inhibitory effect on the trans-
activation potential of c-Jun. However, unexpec-
tedly, we found that exchange of a cluster of six
charged amino acids immediately adjacent to the
DNA contact region altered significantly transcrip-
tional activity of chimeras. This particular subdo-
main could be involved in efficient presentation of
the AP-1 complex to the transcriptional machinery.
To confirm this role, specific residues present in the
cluster of HBZ were substituted for corresponding
amino acids in c-Fos. Unlike the JunD-activating
potential of wild-type HBZ, this mutant was no
longer able to stimulate JunD activity, confirming
the key role of this particular cluster in regulation of
Jun transcriptional potency.
INTRODUCTION
Transcription initiation is regulated by the assembly of a
large multiprotein complex on the promoter region of genes
(1). In their simplest form, interactions regulating transcrip-
tional activity involve direct protein–protein contacts
between components of the general transcription machinery
and transcriptional activators bound to the promoter. Het-
erodimerization of many transcriptional regulatory proteins
provides mechanisms for combinatorial regulation of gene
expression. Among these transcriptional factors, the Fos
(c-Fos, FosB, Fra-1 and Fra-2) and Jun (c-Jun, JunB and
JunD) proteins are proto-oncogene products that regulate a
diverse array of genes in response to mitogenic signals (2).
These proteins belong to the AP-1 family of transcription fac-
tors. Fos-Jun heterodimers and Jun homodimers bind DNA,
whereas the Fos homodimer is unstable and does not bind
DNA. The Fos-Jun heterodimer is also capable of binding
cooperatively with members of other transcription factor
families.
Fos, Jun and the other AP-1 proteins are DNA-binding
proteins, which are members of the family of basic-leucine
zipper (bZIP) factors. On the basis of their amino acid
sequence, the zipper motif was ﬁrst identiﬁed as a heptad
repeat of leucines interspersed with other hydrophobic resi-
dues. These regions form long a-helices that dimerize by
forming a parallel coiled-coil. The basic region, located
N-terminal to the coiled-coil, mediates DNA contacts. The
basic region becomes ordered upon binding to DNA, forming
an a-helix that lies in the DNA major groove and contacts
speciﬁc base and phosphate groups. Recently, we have
demonstrated that the oncogenic retrovirus HTLV-I (human
T-cell leukaemia virus type I) codes for a bZIP factor,
which was appropriately named HBZ (HTLV-I bZIP factor)
(3). This novel HTLV-I-encoded protein is a 31 kDa protein
that resembles a prototypical bZIP transcriptional factor (3),
with an N-terminal transcriptional activation domain, a cent-
ral domain involved in nuclear localization, and a C-terminal
bZIP domain (4). HBZ interacts with c-Jun (5,6), JunB (5)
and JunD (7) but is unable to interact with c-Fos (6) and to
form stable homodimers (5). However, although HBZ and
c-Fos can interact with c-Jun, they differ greatly in their
abilities to activate transcription of AP-1-regulated genes.
Indeed, unlike c-Fos, the interaction of HBZ with c-Jun res-
ults in the decrease of c-Jun DNA-binding activity (5,6) and
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dependent promoters and the basal expression of the
HTLV-I promoter (5).
This difference between HBZ and c-Fos function provides
an opportunity to better characterize the molecular mechan-
isms involved in the HBZ-mediated down-regulation of
c-Jun activity. In this study, we generated and analyzed a
large number of HBZ/c-Fos chimeras and found that the
HBZ-mediated repression of c-Jun transcriptional activity is
due to several substitutions of important amino acid residues
in its DNA-binding domain. However, unexpectedly, we
also found that exchange of a cluster of six amino acids, con-
taining basic and acidic residues immediately adjacent to the
DNA contact region, affected the transcriptional potency of
the chimeras. This new data suggest that HBZ contains a
short modulatory domain that is involved in determining the
strength of the transcriptional response. To explain this unex-
pected observation, we then speculated that this particular sub-
domain of HBZ could be involved in the presentation of the
AP-1 complex to the transcriptional machinery. In order to
test this hypothesis, speciﬁc residues present in the cluster
sequence of HBZ were substituted for the corresponding
c-Fos amino acids and the effect of the mutated HBZ was
tested in the presence of JunD. Indeed, as already described
(7), the JunD DNA-binding activity was not modiﬁed in the
presence of the wild-type HBZ and its transcriptional activity
was stimulated. On the other hand, the mutated HBZ was no
longer able to stimulate the transcriptional activity of JunD
although no decreasing of the JunD DNA-binding activity
was observed. This result conﬁrms the involvement of this
particular cluster in the modulation of Jun transcriptional
potency. In addition, taken together, our results demonstrate
that HBZ can now be considered as a novel member of the
AP-1 family.
MATERIALS AND METHODS
Plasmid constructs
The pcDNA-HBZ-Myc vector has already been described (7).
pCMV-JunD, pcDNA-c-Jun, pcDNA-JunB and pcDNA-
c-Fos constructs were obtained from M. Piechaczyk. To
generate the HBZ209/Fos chimera, the c-Fos cDNA was
PCR ampliﬁed from the pcDNA-c-Fos vector, digested with
HindIII, and subcloned in frame into HindIII-linearized
pcDNA-HBZ-Myc, to produce a Myc-tagged chimera. The
pcDNA-HBZ122-Myc vector was constructed by digesting
pBIND-HBZ122 (3) with BamHI and KpnI and by subclon-
ing the resulting HBZ fragment into similarly digested
pcDNA3.1( )/Myc-His. The c-Fos c-DNA digested by KpnI
was then introduced in frame into the KpnI cloning site of the
linearized pcDNA-HBZ122-Myc to produce the Myc-tagged
chimeras HBZ122/Fos and HBZ122/bZIPFos. Different frag-
ments of HBZ DNA were ampliﬁed by PCR and subcloned
into pcDNA3.1( )/Myc-His generating pcDNA-HBZ130-
Myc, pcDNA-HBZ140-Myc and pcDNA-HBZ163-Myc.
The c-Fos cDNA was then cloned in frame in these latter con-
structs using the HindIII restriction site to obtain HBZ130/
bZIPFos and HBZ163/ZIPFos. For the pcDNA-HBZ140/
bZIPFos construct, ampliﬁed c-Fos cDNA was ﬁrst cloned
into BamHI/HindIII-digested pcDNA-HBZ140-Myc. The
artiﬁcially introduced BamHI site was then deleted to elimin-
ate the two amino acids due to the insert of the restriction site
and to reintroduce accurate amino acid sequence. Site-
directed mutagenesis was performed using the QuikChange
site-directed mutagenesis kit (Stratagene) to produce H3F,
H6F, H9F, H12F, H14F, EEEERE, EEEERR, HBZ and
c-Fos mutants. All of the constructs were sequenced to ensure
that no unintended mutations were introduced during PCR
ampliﬁcation.
Analysis of in vivo expression of the chimeras by
western blot analyzes
293T cells were transfected with 3 mg of expression vector
using the jetPEI  transfection reagent (Qbiogene). A total
of 200 mg of protein extracts from transfected 293T cells
were electrophoresed on to SDS–PAGE and blotted to poly-
vinylidene diﬂuoride (PVDF) membranes (Millipore). Mem-
branes were then incubated 1 h at room temperature in a
blocking solution (phosphate-buffered saline [PBS] contain-
ing 5% milk) prior to addition of antiserum. The chimeras
tagged with the Myc epitope, fused to their C-terminal end,
were detected with the mouse anti-Myc antibody 9E10
(Sigma). After 1 h, membranes were washed three times
with PBS-0.5% Tween-20 and incubated for 1 h with goat
anti-mouse immunoglobulin-peroxydase conjugate. After
three washes, membranes were incubated with the enhanced
chemiluminescence (ECL) reagent (Amersham Pharmacia
Biotech). Membranes were then exposed to hyperﬁlms-ECL
(Amersham Pharmacia Biotech).
Immunofluorescence microscopy analysis
After transfection with 1 mg of expression vector as described
above, COS cells were cultivated on the glass slides and then
analyzed by ﬂuorescent microscopy at 36 h after transfection.
The chimeras tagged with the Myc epitope were detected
with the mouse anti-Myc antibody 9E10 (Sigma) and second-
ary goat anti-mouse IgG antibody coupled to FITC (Pierce).
The same approach was carried out with COS cells transfec-
ted with pcDNA-c-Fos labeled with mouse anti-c-Fos
antibody from Santa Cruz Biotechnology.
Cotransfections and luciferase assays
CEM cells were transiently cotransfected according to the
previously published procedure (8). A total of 5 mgo f
pcDNA3.1-lacZ (b-galactosidase-containing reference plas-
mid) was added in each transfection for controlling of the
transfection efﬁciency. The total amount of DNA in each
transfection was kept constant through the addition of appro-
priate quantities of empty plasmids. Equal amounts of pro-
teins from each cell extracts were then used for luciferase
and b-galactosidase assays.
Microwell colorimetric AP-1 assays
Nuclear extracts (15 mg) were incubated with 30 ml of binding
buffer [10 mM HEPES (pH 7.5), 8 mM NaCl, 12% glycerol,
0.2 mM EDTA, 0.1% BSA] in microwells coated with probes
containing the AP-1 site (Trans-AM  AP-1 of Active Motif
Europe, Belgium). After a 1 h incubation at room temperat-
ure, microwells were washed three times with PBS containing
0.1% Tween-20. The AP-1-bound complexes were detected
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antibody followed by the addition of a secondary peroxydase-
conjugated antibody. For colorimetric detection, tetramethyl-
benzidine was incubated at room temperature before addition
of the stop solution. Optical density was read at 450 nm,
using a 620 nm reference wavelength with a Tecan micro-
plate reader.
Two-hybrid assays in yeast
Interactions between the chimeras and c-Jun were analyzed
by two-hybrid assay in Saccharomyces cerevisiae strain
HF7c. Strain HF7c possesses the Escherichia coli lacZ gene
driven by three copies of the GAL4 consensus sequence. The
region of the chimeras containing the bZIP domain (from 123
to 209 amino acid) was cloned in frame with the GAL4 DNA-
binding domain of the pGBT9 vector. Chimera cDNA was
PCR ampliﬁed from pcDNA-HBZ/c-Fos-Myc, digested by
EcoRI and BamHI, and cloned into pGBT9. Yeasts were
cotransformed with pGBT9 and pGAD-c-Jun or pGAD-
JunD as already described (9). The b-galactosidase assay
with o-nitrophenyl-b-D-galactopyranoside (ONPG) as sub-
strate was carried out on three independent colonies per trans-
formation according to the manufacturer’s protocol
(Clontech). The b-galactosidase activity was calculated in
Miller units (10).
RESULTS
Analysis of chimeric proteins between HBZ and c-Fos
We have previously reported that, unlike c-Fos, a typical het-
erodimer partner of c-Jun, HBZ inhibited the trans-activating
potential of c-Jun (5). To analyze whether the distinct beha-
vior of HBZ and c-Fos could be attributable to speciﬁc
regions of the protein, chimeras were constructed by swap-
ping fragments of c-Fos and HBZ using restriction sites arti-
ﬁcially introduced within inactive regions located between
their activation domains and their DNA-binding domain.
On the other hand, for chimeric constructs directly targeting
functionally important regions, such as the bZIP domain (11),
a restriction site was strategically added thereby maintaining
correct phasing between the basic region and leucine zipper.
For constructs in which this strategy was not feasible, the
restriction site was deleted to regenerate the accurate amino
acid sequence. All chimeric DNAs were inserted into the
mammalian expression vector pcDNA3.1( )/Myc-His per-
mitting Myc tagging of each chimera at the C-terminus.
In vivo expression of each chimera was analyzed by western
blotting and their ability to interact with c-Jun was tested by a
two-hybrid assay in yeast. Finally, the transcriptional activity
of the wild-type and chimeric proteins were tested by cotrans-
fection of corresponding expression vectors into CEM cells
with pcDNA-c-Jun and a luciferase reporter vector carrying
the AP-1-driven collagenase promoter.
The c-Fos protein contains ﬁve activation modules: two in
its N-terminal region (12) and three others at its C-terminal
end (13,14) while HBZ only possesses a single activation
domain located in its N-terminal end (3). We ﬁrst produced
two chimeric constructs, HBZ122/Fos and HBZ209/Fos,
depicted in Figure 1. Both chimeras contain the N-terminal
activation domain of HBZ and the three C-terminal activation
modules of c-Fos but differ in amino acid sequence from resi-
due 123 to 209, which includes their respective bZIP domain
(from residue 140 to 200). While HBZ122/Fos possesses the
c-Fos bZIP domain, HBZ209/Fos contains the reciprocal
HBZ bZIP domain (Figure 1). We ﬁrst conﬁrmed that both
chimeras were stably expressed in transfected cells
(Figure 2A) and were capable of interacting with c-Jun
(data not shown). Upon cotransfection of each expression
vector with the collagenase promoter-luciferase construct in
CEM cells, we found that, similar to HBZ, the HBZ209/Fos
chimera inhibited c-Jun activity while HBZ122/Fos, like
c-Fos, maintained its activating potential toward c-Jun-
dependent transcriptional activation (Figures 1 and 2B). To
determine if the c-Fos activation domains AD3, AD4 and
AD5 might contribute to this difference in c-Jun activation
between both chimeras, we produced a novel chimera derived
from the ﬁrst 209 amino acids and termed HBZ122/bZIPFos,
possessing the N-terminal activation domain of HBZ fused to
the c-Fos region (residues 123 to 209) that contains the c-Fos
bZIP domain (Figure 1). In the presence of HBZ122/bZIPFos,
c-Jun was able to activate AP-1-dependent transcription
(Figures 1 and 2C). Taken together, these data suggest that
the HBZ region located between 123 and 209 amino acids
is responsible for the HBZ inhibitory effect on the trans-
activation potential of c-Jun.
The cluster of residues immediately adjacent to the
HBZ bZIP domain can negatively modulate
c-Jun-dependent transcription
To better deﬁne the domains of HBZ involved in its repres-
sion activity, HBZ/c-Fos chimeras targeting shorter regions
were derived. As shown in Figures 1 and 2C, the HBZ163/
ZIPFos chimera was unable to stimulate AP-1-transcription
in the presence of c-Jun, conﬁrming the involvement of the
DNA-binding domain of HBZ in its inhibitory action on
c-Jun activity, as already suggested (5,6). On the other
hand, HBZ130/bZIPFos and HBZ140/bZIPFos, both con-
taining the bZIP domain of c-Fos, retained their capacity to
trans-activate AP-1-transcription in the presence of c-Jun.
However, unexpectedly, whereas HBZ130/bZIPFos was
found to stimulate c-Jun dependent expression of the luci-
ferase reporter gene by about 195-fold, i.e. at comparable
levels to HBZ122/bZIPFos, luciferase activity was only
enhanced by 39-fold upon transfection of the HBZ140/
bZIPFos expression vector (Figure 2C).
To identiﬁy amino acids responsible for the functional dif-
ferences observed between HBZ130/bZIPFos and HBZ140/
bZIPFos chimeras, amino acid sequences of HBZ and c-Fos
were compared in the 130–140 amino acid cluster
(Figure 3A). It is worth noting that c-Fos in this region con-
tains a stretch of six charged residues (EEEEKR from resi-
dues 134 to 139) that are only partially conserved in the
HBZ sequence (EQERRE). Mutational analysis was thus
targeted towards these residues. To determine which of
these amino acids were important, HBZ-speciﬁc residues
were replaced in HBZ140/bZIPFos with the corresponding
c-Fos amino acid. We ﬁrst constructed a mutant for which
EQERRE was changed to EEEERE in order to reintroduce
two negatively charged residues. The effect of this double
Nucleic Acids Research, 2006, Vol. 34, No. 9 2763mutation was signiﬁcant since the mutant activated expres-
sion of the luciferase reporter gene in the presence of c-Jun
up to 125-fold (Figure 4A). A third modiﬁcation (E
139 into
R) was introduced in the cluster thereby generating
the EEEERR amino acid stretch. This mutation resulted in
210-fold activation of the collagenase promoter, which was
comparable to the activating potential of the HBZ130/
bZIPFos chimera (Figure 4A). These data show that both
the DNA-binding domain and the amino acid cluster adjacent
to the bZIP domain can affect the trans-activating potency of
the chimeras toward c-Jun-dependent transcription.
The EQERRE motif of HBZ does not modify
DNA-binding activity of the c-Fos bZIP domain
A possible explanation for our results is that the increased
trans-activating potency of the chimeras results from an
increase in their stability. This explanation was however
ruled out by the results shown in the Figure 4B. HBZ140/
bZIPFos and the two resulting mutants demonstrated protein
levels comparable to HBZ130/bZIPFos in transfected cells.
We also found that the chimeras were able to interact with
c-Jun (Figure 4C). Another possible explanation for the
observed difference in activating potential is that this cluster
of six amino acids, particularly rich in charged residues and
immediately adjacent to the DNA contact region, may inter-
fere with the binding to the AP-1 motif. To test this possibil-
ity, we compared the DNA-binding activity of HBZ140/
bZIPFos (EQERRE) with that of its mutated EEEERR
form. To evaluate DNA-binding, we used the microwell col-
orimetric assay from Active Motif Europe (15) which we had
previously used for the study of complex formation between
c-Jun, HBZ and the AP-1 motif (5). Brieﬂy, nuclear extracts
of 293T cells transfected with c-Jun and either HBZ, c-Fos or
HBZ/c-Fos chimera expression vectors were incubated in the
presence of a double-stranded oligonucleotide containing the
AP-1 site immobilized on a microwell plate. The DNA-
binding activity was then measured by colorimetric assay
using mouse anti-c-Jun antibodies. As shown in Figure 4D,
there was no signiﬁcant difference between the binding
Figure 1. Structures of the chimeric proteins between c-Fos and HBZ and their effect on the trans-activation by c-Jun. Schematic representations of c-Fos, HBZ,
and the various chimeras are shown; the chimeric proteins possess one or several activation domains (AD) and a bZIP structure including the DNA-binding
domain (from residue 140 to 163) and the zipper (from 164 to 200). Expression plasmids of c-Fos, HBZ, and their chimeras were cotransfected with
c-Jun expression plasmid together with a vector containing the luciferase gene driven by the collagenase promoter as described in the legend of Figure 2. The
results are indicated on the right. Symbols: +++++, activation above 800-fold; +++, about 200-fold; +, about 40-fold; -, inhibition of c-Jun activity.
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binding. This result was expected since the hexapeptide
EEEEKR is not included in the amino acid sequence of the
c-Fos bZIP domain known to be in contact with the AP-1
site in the presence of c-Jun (16). In conclusion, our data sug-
gest that a stretch of six charged residues immediately adja-
cent to the bZIP domain of HBZ and c-Fos affects the
transcriptional potency of the AP-1 complexes on targeted
promoters.
The DNA-binding domain of HBZ is involved in the
down-regulation of c-Jun activity
We next studied the inﬂuence of association of the hexapep-
tide EEEERR with the DNA-binding domain of HBZ on
c-Jun trans-activation. For these experiments, we decided to
construct a mutant named H3F in which EQERRE was
replaced in HBZ163/ZIPFos by the amino acid sequence
EEEERR (Figure 3B). Unlike HBZ140/bZIPFos, this triple
Figure 2. Characterization of the amino acid region involved in the differential activation of c-Jun by c-Fos and HBZ. (A) Expression of the chimeras HBZ122/
Fos and HBZ209/Fos in vivo. Expression of the chimeric proteins in 293T cells was detected by western blotting using the mouse anti-Myc antibody (NT: not
transfected). Molecular size markers (kDa) are shown on the left and migration of the chimeras is indicated by the arrow on the right. (B and C) Analysis of
the trans-activation by the chimeras in the presence of c-Jun. CEM cells were cotransfected with 2 mg of a vector containing the luciferase reporter gene driven by
the collagenase promoter, 5 mg of pcDNA3.1-lacZ (b-galactosidase-containing reference plasmid), 1 mg of pcDNA-c-Jun and 2 mg of the vector pcDNA3.1( )/
Myc-His expressing each of the tested chimera. Luciferase values are expressed as folf increases relative to values measured in cells transfected with
empty pcDNA3.1( )/Myc-His in the presence of the luciferase reporter vector. The total amount of DNA in each series of transfection was equal, the balance
being made up with the empty plasmids. Luciferase values were normalized for b-galactosidase activity. Values represent the mean ± SD (n ¼ 3).
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c-Jun activity (Figure 5A). This difference can be explained
by the presence of the particular DNA-binding domain of
HBZ in the chimera HBZ163/ZIPFos. Indeed, the DNA-
binding site in bZIP factors is composed of a stretch of
predominantly basic amino acids lying immediately adjacent
to the leucine zipper and containing an array of speciﬁc
residues termed the basic motif corresponding to the con-
sensus sequence bb-bN--AA-b(C/S)R-bb (17–19). The
HBZ basic motif diverges from this consensus, lacking the
conserved N
146,A
150 and R
154 and some basic residues
(R
142,R
145,K
152 and R
157) present in the DNA-binding
domain of c-Fos.
To precisely deﬁne residues that affect HBZ DNA-binding,
speciﬁc amino acids in the HBZ basic motif were substituted
for their equivalent in c-Fos (Figure 3). All mutants generated
from this approach were derived from HBZ163/ZIPFos.
Because N
146,A
150 and R
154 have been described to be highly
conserved, these three residues were ﬁrst reintroduced in the
HBZ basic motif. This novel mutant, named H6F, did not
however stimulate transcription in the presence of c-Jun
(Figure 5A), although it was able to interact with c-Jun
(Figure 5C). Three additional mutants were then produced:
H9F, H12F and H14F, in which additional substitutions
were generated in the HBZ basic motif (Figure 3). Only
mutant H14F, for which 14 amino acid substitution had
been introduced in the amino acid sequence encompassing
residues 135 to 159 of HBZ, enhanced trans-activation in
the presence of c-Jun (Figure 5A). All of the produced
mutants had comparable stability (Figure 5B) and capacity
to interact with c-Jun (Figure 5C).
To conﬁrm that the trans-activity of H14F was effectively
due to its modiﬁed basic region, we compared c-Jun
DNA-binding activity in the presence of H14F and H3F,
two chimeric proteins which only differ in their DNA-binding
domain. Figure 5D shows that their ability to bind to the AP-1
motif was signiﬁcantly different, with H14F/c-Jun heterodi-
mers showing a higher afﬁnity for AP-1 sequence than
H3F/c-Jun heterodimers. Lastly, to rule out aberrant subcellu-
lar localization as an explanation for the absence of trans-
activation for some chimeras, their localization was examined
by immunoﬂuorescence microscopy. As shown in Figure 6,
all chimeras were found to localize to the nucleus.
In conclusion, our results demonstrate that HBZ down-
regulates c-Jun activity mainly by forming a heterodimer
with c-Jun that is severely reduced in its ability to recognize
the AP-1 site.
The EQERRE motif of HBZ positively modulates JunD
transcriptional activity
To better understand the role played by the EQERRE motif in
HBZ, this amino acid cluster was substituted by the amino
acid sequence EEEERR, which is similar to the c-Fos motif
(EEEEKR). Like the wild-type HBZ, this mutated protein,
termed HBZ-mutMD (for mutated modulatory domain),
could interact with Jun factors and was localized in the nuc-
leus (data not shown). Moreover, HBZ-mutMD was stably
expressed in transfected cells (Figure 7A). HBZ has been
described to have different effects depending on its heterodi-
merization partner: while it represses c-Jun activity, HBZ
augments the trans-activating potential of JunD (5,7). For
this reason, the effect of the mutation on HBZ function was
tested in the presence of either c-Jun, or JunD. We ﬁrst ana-
lyzed the DNA-binding activity of c-Jun and JunD in the
presence of HBZ-mutMD. As similarly described for the
wild-type HBZ (5,7), HBZ-mutMD decreased DNA-binding
activity of c-Jun (Figure 7B) but did not signiﬁcantly alter
Figure 3. Comparison of the amino acid region adjacent to the bZIP domain between HBZ and c-Fos. The HBZ and c-Fos DNA-binding domains were aligned
by using the basic motif and leucine zipper as a reference point. Numbering is relative to the +1 methionine of the chimeras shown in Figure 1. (A) The cluster of
six charged residues studied in the paper (134–139 amino acids) is in bold and the leucine residues of the zipper are in boxes. (B) Comparison of the amino acid
sequences adjacent to the leucine zipper of HBZ, c-Fos, and the different mutants produced from HBZ163/ZIPFos. The mutated residues are bold and the basic
motifs of the DNA-binding domains (142–157 amino acids) are in a box. The conserved alanine and serine/cysteine residues of the basic motif correspondt o
position 149 and 153.
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activities of both c-Jun and JunD were then studied in the
presence of wild-type HBZ and its mutated form by cotrans-
fection of their expression vectors into CEM cells. In com-
parison to wild-type, HBZ-mutMD could equally inhibit
c-Jun-mediated transcriptional activity (Figure 7B). This res-
ult conﬁrms that the repressing functional properties of HBZ
on c-Jun activity are mainly due to its DNA-binding domain.
On the other hand, the effect of HBZ-mutMD on JunD activ-
ity was found to be completely different from that of the
wild-type since the mutant could no longer stimulate JunD
transactivating potential (Figure 7C). We also tested the
effect of HBZ-MutMD on JunB activity but, like c-Jun, no
difference between the wild-type and the mutant was
observed (data not shown). Moreover, during the preparation
of this manuscript, it has been published that the HTLV-I
genome can code for a new isoform of HBZ (20,21).
We also mutated this isoform in the EQERRE motif and
the same results were obtained (data not shown). Such an
observation is not surprising since only the ﬁrst four amino
acids differ between both isoforms and our data have
focussed on the modulatory role of the C-terminal region of
the protein. In conclusion, our results demonstrate that the
EQERRE cluster is involved in the activation by HBZ of
JunD-mediated transcriptional activity.
In light of these results, it was interesting to determine
whether an equivalent effect could be observed when the
modulatory domain of HBZ was introduced in the context
of the c-Fos amino acid sequence. Thus, the c-Fos EEEEKR
motif was replaced by the EQERKE sequence, which is sim-
ilar to the HBZ motif (EQERRE). As already shown in
Figures 4 and 7, such a modiﬁcation does not change the
in vivo stability of the protein and its capacity for binding
to the Jun factors and the AP-1 site. The activity of this
new mutant (termed c-Fos-MutMD) was then analyzed in
the presence of c-Jun, JunB and JunD. In the presence of
c-Jun, whereas wild-type c-Fos stimulated expression of the
luciferase reporter gene by 720-fold, luciferase activity was
Figure 4. The EEEEKR sequence immediately adjacent to the bZIP domain of c-Fos confers a trans-activation potential to heterodimerized c-Jun. (A) The
transcriptional activity of the mutated chimeras were analyzed as described in the legend of Figure 2. Bars labeled as EQERRE, EEEERE, EEEERR and
EEEEKR correspond to cells tranfected by HBZ140/bZIPFos, the two mutated chimeras produced from HBZ140/bZIPFos, and HBZ130/bZIPFos, respectively.
For comparison, luciferase activity was also measured from cells transfected with pcDNA-c-Jun alone or in the presence of the wild-type HBZ expression vector.
(B) Expression of the chimeric proteins in 293T cells was detected by western blotting using the mouse anti-Myc antibody as already mentioned. Migration of the
chimeras is shown by the arrow and the asterisks indicate non-specific bands. (C) Interaction study between the generated chimeras with c-Jun by yeast two-
hybrid assay using a liquid culture b-galactosidase assay. Yeasts were transformed with the expression vector pGAD containing the entire coding sequence of
c-Jun fused to the GAL4 activation domain along with pGBT9 expressing the GAL4 DNA-binding domain fused to the region encompassing residues 123 to 209
from c-Fos, HBZ, or the chimeras. The b-galactosidase was carried out on three independent colonies per transformation assay using ONPG as substrate. Mean
values presented in the graph are expressed in Miller units. (D) DNA-binding activity of chimeras. Microwells containing the AP-1 binding probe were incubated
with nuclear cell extracts of 293T cells cotransfected with 4 mg of pcDNA-c-Jun and 4 mg of the vector expressing c-Fos, HBZ, HBZ140/bZIPFos (EQERRE) or
its mutated form (EEEERR). The negative and positive controls correspond to cells transfected by the pcDNA empty vector and pcDNA-c-Jun alone. The data
represent the means of three values ± S.D. Above, immunoblotting of nuclear proteins from transfected 293T cells using anti-c-Jun antibodies.
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MutMD expression vector (Figure 8). This result shows that
the modulatory domain of c-Fos affects the transcriptional
potency of the c-Fos/c-Jun heterodimer, conﬁrming our res-
ults with the HBZ/c-Fos chimeras. On the other hand, the
effects were less drastic with the two other Jun factors,
especially with JunB (Figure 8). In the presence of JunB, luci-
ferase activity was stimulated by 400- and 320-fold by c-Fos
and c-Fos-mutMD, respectively. Nonetheless, these data
indicate that the modulatory domain is crucial for regulation
of c-Jun transcriptional potency by c-Fos.
DISCUSSION
An earlier study from our team had for the ﬁrst time demon-
strated the existence of a bZIP transcriptional factor encoded
on the complementary strand of the HTLV-I RNA genome
(3). Subsequent studies from our group and others have
demonstrated that HBZ inhibits c-Jun activity by forming het-
erodimers deﬁcient in their ability to form stable complexes
on the AP-1 motif (5,6). Sequence comparison indicates that
HBZ possesses a particular DNA-binding domain that lacks
the consensus amino acid sequence bb-bN--AA-b(C/S)R-bb
thought to be critical for DNA-binding (3,22). It was
therefore anticipated that this defective DNA-binding domain
would contribute importantly to the functional differences
between HBZ and c-Fos. Indeed, in this study, the generation
of the different chimeras through the swapping of various
segments of c-Fos and HBZ indicates that this basic motif
has an important impact on the transcriptional activity
observed for both transcription factors in the presence of
c-Jun. However, we also found that swapping of an amino
acid cluster rich in charged residues (EEEEKRR in c-Fos
substituted for EQERRER in HBZ) affects transcriptional
potency of the chimeras. Thus, HBZ and c-Fos possess spe-
ciﬁc amino acid motifs immediately adjacent to their DNA-
binding domain involved in determining the strength of
their transcriptional response. This conclusion is not only
based on our results but also on the study of the transforming
properties of c-Fos. Indeed, analysis of mutant c-Fos proteins
has shown that the presence of an intact EEEEKRR motif is a
prerequisite for the induction of transformation (23). The
presence of such a modulatory sequence is not the only com-
mon point between HBZ and the members of the Fos-protein
family. Indeed, HBZ does not form stable homodimers (5)
and is unable to interact with c-Fos (6). On the other hand,
like c-Fos, HBZ interacts with c-Jun, JunB and JunD (5–7).
Taken together, all these observations suggest that HBZ
needs to be classiﬁed as a new member of the AP-1 family.
Figure 5. Activity analysis of c-Fos substitution mutants in the HBZ DNA-binding domain. (A) The transcriptional activity and (B) in vivo expression were
analyzed as described in the legend of Figure 2. (C) The interaction with c-Jun and (D) the DNA-binding activity of H3F and H14F mutants were tested as
described in the legend of Figure 4.
2768 Nucleic Acids Research, 2006, Vol. 34, No. 9We also demonstrate that mutations in the c-Fos
EEEEKRR motif do not alter the capacity of the protein to
bind to the AP-1 site and to interact with Jun factors. These
observations suggest that this sequence could play a role in
the architecture of the protein complexes bound to the pro-
moter. c-Fos/c-Jun heterodimers have been found to induce
DNA bending (24,25) and substitution of two basic residues
(R
139 and R
140 of the Figure 3) adjacent to the c-Fos bZIP
domain by neutral and acidic residues resulted in a reduction
in DNA bending (26). Thus, residues adjacent to the bZIP
domain are likely to inﬂuence DNA bending (27,28). More-
over, it has also been demonstrated that DNA bending
determines c-Fos/c-Jun heterodimer orientation and that the
orientation of the DNA-bound complex strongly affects its
transcriptional potency (29,30). Again it has been clearly
shown that the basic residues KRR inﬂuence the orientation
of heterodimer binding to the AP-1 site (30,31). All these
observations could explain why mutation of the amino acid
sequence EQERRER into EEEERRR was required to obtain
full transcriptional activation in the presence of c-Jun. How-
ever, the chimeric mutant EEEERER was able to signiﬁcantly
stimulate AP-1-dependent transcription although it did not
contain the KRR motif adjacent to its bZIP domain. These
results suggest that the acidic domain adjacent to the basic
residues could also be involved in the formation of a potent
transcriptional complex. Moreover, a negatively charged
region located at a more distant position from the bZIP
domain of c-Jun has been suggested to induce DNA bending
in the opposed direction from the bending caused by the bind-
ing of Jun homodimers and to counteract c-Fos-dependent
DNA bending in the context of heterodimers (26). The tran-
scription activation domains of c-Fos and c-Jun, which
contain clusters of charged residues, also induce DNA bend-
ing (32). Altogether, these observations suggest that DNA
bending by c-Fos and c-Jun is mediated at least in part by
charge interactions. In conclusion, the cluster of acidic resi-
dues at the extreme N-terminal end of the c-Fos bZIP domain
might be at a sufﬁciently close proximity to the DNA back-
bone to inﬂuence the protein architecture of the AP-1-bound
complex. This issue would be of particular importance with
respect to the spatial relationship of the activation domain
with chromatin remodelling factors and proteins associated
with RNA polymerase II.
It is worth noting that the presence of this particular cluster
in HBZ modulates JunD activity. Unlike c-Jun, HBZ does not
reduce the JunD ability to bind to the AP-1 site. Moreover,
HBZ stimulates the JunD transcriptional activity (7). Interest-
ingly, when the HBZ EQERRE motif was substituted by the
c-Fos modulatory domain, the mutated HBZ was no longer
able to stimulate the transcriptional activity of JunD although
Figure 6. Subcellular localization of HBZ, c-Fos and the different chimeras in COS cells. Expression vectors for HBZ, c-Fos and the different chimeras were
transiently transfected into COS cells. Cells were cultivated on glass sides, fixed, and stained with the Hoechst solution. The localization of the Myc-tagged
chimeras was analyzed by immunofluorescence microscopy using the mouse anti-Myc antibody and goat anti-mouse IgG antibodies coupled to FITC. The blue
fluorescence of the nuclei results from ultraviolet (UV) illumination of the fixed cells.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2769no decreasing of the JunD DNA-binding activity was
observed. At ﬁrst glance, this result seems paradoxical even
though the regulation of JunD activity, compared to c-Jun,
is known to be different. Indeed, JunD might not normally
exist in a free form, but only as a complex with menin
(33). This factor is the product of the multiple endocrine neo-
plasia type 1 gene and is known to be a tumor suppressor.
Menin speciﬁcally interacts with JunD (and not with c-Jun)
Figure 7. The EQERRE sequence immediately adjacent to the bZIP domain of HBZ confers a trans-activation potential to JunD. In vivo expression of the HBZ-
mutMD protein (A) and its effect on c-Jun (B) or JunD (C) DNA binding (on the left) and transcriptional (on the right) activities were analyzed as described in
the legends of the other figures.
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(34,35). Menin represses JunD transcriptional activity by
recruiting a histone deacetylase complex through association
with mSin3A, a transcriptional corepressor (36). It is tempt-
ing to speculate that the presence of HBZ might inﬂuence
the recruiting of HDACs by JunD. Experiments are underway
to further evaluate further this possibility. Moreover, the
results obtained with our HBZ mutant modiﬁed in the modu-
latory domain strengthen the idea that this particular cluster
present in HBZ would inﬂuence the architecture of Jun
proteins bound to the promoter, thus forming a complex
with lesser accessibility to transcriptional regulators, i.e.
activators for c-Jun and repressors for JunD.
In conclusion, we demonstrate that, in its C-terminal
region, HBZ possesses two subdomains involved in the regu-
lation of the trans-activation potential of Jun factors. The
DNA-binding domain of HBZ seems preferentially involved
in the down-regulation of c-Jun by forming heterodimers with
a reduced stability on the AP-1 site when compared to c-Jun
homodimers. This HBZ-speciﬁc negative effect on c-Jun
transcriptional activating function could lead to the inhibition
of viral transcription (5,37). On the other hand, the second
domain corresponding to a cluster of six charged amino
acids might rather be involved in the modulation of JunD
activity. Moreover, the presence of the activation domain of
HBZ has also been described to be necessary for trans-activa-
tion of JunD (7) but not to be an important modulator of viral
transcription (3), suggesting that the effect of HBZ on JunD
could have a stronger impact on the control of cellular pro-
moters. In addition, taken together, our results demonstrate
that HBZ can be considered as a novel member of the
AP-1 family and conﬁrm the potential role of HBZ in the
control of the development of HTLV-I-associated pathologies
including adult T-cell leukaemia (ATL) and inﬂammatory
disorders.
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